References
- 1Reynolds HR, Hochman JS. Cardiogenic shock: Current concepts and improving outcomes. Circulation. 2008; 117: 686–697. DOI: 10.1161/CIRCULATIONAHA.106.613596
- 2Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction–etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36(3 Suppl A): 1063–1070. DOI: 10.1016/S0735-1097(00)00879-2
- 3Jones TL, Nakamura K, McCabe JM. Cardiogenic shock: evolving definitions and future directions in management. Open Heart. 2019; 6:
e000960 . DOI: 10.1136/openhrt-2018-000960 - 4Harjola VP, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015; 17: 501–509. DOI: 10.1002/ejhf.260
- 5Kolte D, Khera S, Aronow WS, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014; 3:
e000590 . DOI: 10.1161/JAHA.113.000590 - 6Rathod KS, Koganti S, Iqbal MB, et al. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group. Eur Heart J Acute Cardiovasc Care. 2018; 7: 16–27. DOI: 10.1177/2048872617741735
- 7Helgestad OKL, Josiassen J, Hassager C, et al. Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: A Danish cohort study. Eur J Heart Fail. 2019; 21: 1370–1378. DOI: 10.1002/ejhf.1566
- 8Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367: 1287–1296. DOI: 10.1056/NEJMoa1208410
- 9Aissaoui N, Puymirat E, Tabone X, et al. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: A report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J. 2012; 33: 2535–43. DOI: 10.1093/eurheartj/ehs264
- 10De Luca L, Olivari Z, Farina A, et al. Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes. Eur J Heart Fail. 2015; 17: 1124–1132. DOI: 10.1002/ejhf.339
- 11Kristensen SL, Martinez F, Jhund PS, et al. Geographic variations in the PARADIGM-HF heart failure trial. Eur Heart J. 2016; 37: 3167–74. DOI: 10.1093/eurheartj/ehw226
- 12van Diepen S, Katz JN, Albert NM, et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017; 136: e232–e268. DOI: 10.1161/CIR.0000000000000525
- 13Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001; 38: 2114–30. DOI: 10.1016/S0735-1097(01)01702-8
- 14Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: A population-based perspective. Circulation. 2009; 119: 1211–1219. DOI: 10.1161/CIRCULATIONAHA.108.814947
- 15Goldberg RJ, Makam RC, Yarzebski J, McManus DD, Lessard D, Gore JM. Decade-Long Trends (2001–2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2016; 9: 117–125. DOI: 10.1161/CIRCOUTCOMES.115.002359
- 16Lindholm MG, Boesgaard S, Torp-Pedersen C, Køber L, TRACE registry study group. Diabetes mellitus and cardiogenic shock in acute myocardial infarction. Eur J Heart Fail. 2005; 7: 834–839. DOI: 10.1016/j.ejheart.2004.09.007
- 17ACCESS Investigators. Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies. Am Heart J. 2011; 162: 852–859.e22. DOI: 10.1016/j.ahj.2011.07.029
- 18Mohanan PP, Mathew R, Harikrishnan S, et al. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: Results from the Kerala ACS Registry. Eur Heart J. 2013; 34: 121–9. DOI: 10.1093/eurheartj/ehs219
- 19Berg DD, Bohula EA, van Diepen S, et al. Epidemiology of Shock in Contemporary Cardiac Intensive Care Units. Circ Cardiovasc Qual Outcomes. 2019; 12:
e005618 . - 20De Luca G, Savonitto S, Greco C, et al. Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2008; 9: 1023–1029. DOI: 10.2459/JCM.0b013e328304ae7f
- 21Webb JG, Sleeper LA, Buller CE, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: A report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000; 36: 1084–1090. DOI: 10.1016/S0735-1097(00)00876-7
- 22Awad HH, Anderson FA,
Jr , Gore JM, Goodman SG, Goldberg RJ. Cardiogenic shock complicating acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2012; 163: 963–971. DOI: 10.1016/j.ahj.2012.03.003 - 23Sleeper LA, Reynolds HR, White HD, Webb JG, Dzavík V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: A report from the SHOCK Trial and Registry. Am Heart J. 2010; 160: 443–450. DOI: 10.1016/j.ahj.2010.06.024
- 24Katz JN, Stebbins AL, Alexander JH, et al. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J. 2009; 158: 680–687. DOI: 10.1016/j.ahj.2009.08.005
- 25Anderson ML, Peterson ED, Peng SA, et al. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR. Circ Cardiovasc Qual Outcomes. 2013; 6: 708–715. DOI: 10.1161/CIRCOUTCOMES.113.000262
- 26Shaefi S, O’Gara B, Kociol RD, et al. Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc. 2015; 4:
e001462 . DOI: 10.1161/JAHA.114.001462 - 27Sieweke JT, Berliner D, Tongers J, et al. Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure. Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure. Eur Heart J Acute Cardiovasc Care. 2020; 9: 138–148. DOI: 10.1177/2048872618757393
- 28Rathod KS, Koganti S, Iqbal MB, et al. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group. Eur Heart J Acute Cardiovasc Care. 2018; 7: 16–27. DOI: 10.1177/2048872617741735
- 29Shah M, Patnaik S, Patel B, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol. 2018; 107: 287–303. DOI: 10.1007/s00392-017-1182-2
- 30Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: Incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014; 64: 1407–1415. DOI: 10.1016/j.jacc.2014.07.958
- 31Chioncel O, Parissis J, Mebazaa A, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020; 22: 1315–1341. DOI: 10.1002/ejhf.1922
